SC 13G Filing

Company

ABVC BIOPHARMA, INC.

Filed

February 26, 2009

Accession Number

0001140361-09-005140

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →